See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
News Digest / Income Statements

Income Statements
09:04am, Tuesday, May 06, 2025
Krystal Biotech Reports Soaring Q1 Revenue, Navigates Challenges Ahead with VYJUVEK Growth
Company Overview: Krystal Biotech, Inc. (NASDAQ: KRYS) is a biotechnology company focused on developing and commercializing genetic medicines. The company's lead product, VYJUVEK, has recently received FDA and EMA approvals for treating dystrophic epidermolysis bullosa (DEB). Recent Financial Per...
Read More